<DOC>
	<DOC>NCT00378456</DOC>
	<brief_summary>The trial aimed to examine the effects of supplementation with antioxidants and folinic acid on the health, growth and psychomotor development of children with Down syndrome. 156 children with Trisomy 21, less than 7 months of age were recruited and randomised into four groups to receive antioxidants, folinic acid, a combination of antioxidants and folinic acid or a placebo. Blinded outcome assessment was carried out 18 months later.Blood and urine samples were also taken around 12 months of age to examine metabolic effects of supplementation.</brief_summary>
	<brief_title>Vitamins and Minerals for Children With Downs Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<mesh_term>Retinol palmitate</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>Under 7 months of age Trisomy 21 Live in recruitment Areai.e. London inside M25, in West Midlands or SW England. One parent speaks English No life threatening cardiac disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>7 Months</maximum_age>
	<verification_date>September 2006</verification_date>
</DOC>